Claris LifeSciences to Expand in Europe, Ties up with STADA Arzneimittel Subsidiaries

« Pfizer Won Norvasc Patent Against Synthon Pharmaceuticals | Main | Dynavax and AstraZeneca to Co-Develop TLR-9 Agonists for Asthma and COPD »

Sep 7

Gloria Gamat

September 7, 2006

Know More: Drug Marketing, Manufacturers & Mergers

Ahmedabad-based Claris Lifesciences, a producer of large and small volume Injectables, has tied up with the subsidiary companies of Germany's third largest generic drug manufacturer, STADA Arzneimittel AG (SAZ). Under the agreement, Claris will supply four products each to STADA's subsidiaries:

Plasmaselect in Germany
Eurogenerics in Belgium,
EG Labo in France and
EG S.p.A in Italy.

"We are hoping to clock first year's sales of about Rs 75 crore or 10% of the Rs 750 crore market for our products in these three countries", Sushil Handa, founder CEO said. Making a projection for the future.

Handa said that they are looking at capturing 28-30% of the total market share of these products, which includes Propofol and Anti-infectives.

Source: Claris

related entries

0 Comments/Trackbacks

submit a trackback

TrackBack URL for this entry:

Comment Preview

« Pfizer Won Norvasc Patent Against Synthon Pharmaceuticals | Main | Dynavax and AstraZeneca to Co-Develop TLR-9 Agonists for Asthma and COPD »

Advertise

Watch the Digital Health Revolution

Related Resources

Advertise Here

Current News

Press Releases

resources

Bookmark this Page
Write for us
About us
Team
Contact
Subscribe
Advertise
Network Map
Privacy
Disclaimer

Support This Blog

Know More Media - Health Care / Pharmaceutical / Fitness

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed

we support unitus

PRWeb

Influencer

PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 619

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 620

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 621

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 622

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 737

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 738

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 739

Warning: date() expects parameter 2 to be long, string given in /usr/www/users/chrisycm/kmm-network/includes/rss2html/rss2html.php on line 740

Pharmaceutical Industry discussion, review, analysis, news and information.

related entries

0 Comments/Trackbacks

submit a trackback

post a comment

Comment Preview

Advertise

Related Resources

recent comments

sponsored ads

topics

subscribe